Abstract:Defects in the intrinsic plasma membrane repair function underlie the progression of many human diseases associated with membrane repair disruptions, such as ischemia/reperfusion damage and similar injuries to the cardiovascular system. Our previous experimental results showed that mitsugumin 53 (MG53), a novel muscle enriched protein from the tripartite motif (TRIM) family (known as TRIM72), is an essential component of the cell membrane repair machinery that protects injury to skeletal muscle and the myocardium. We recently determined that recombinant human MG53 (rhMG53) protein can be applied directly to cells or animal models to increase membrane repair in muscle cells, showing the potential of rhMG53 as a protein therapeutic agent. At the molecular level, MG53 can form dimers to allow movement of intracellular vesicles to patch membrane injury sites. Dimerization through their central coiled‐coil domain is a common property of TRIM proteins, which open the possibility that other TRIM proteins could form heterodimers with MG53. We screened for novel TRIM proteins that can increase membrane repair capacity and found that one such TRIM, TRIM27, can interact with MG53 to form heterodimers. The role of these homo‐ and heterodimers in the cardiac membrane repair is unclear and has to be elucidated in future studies. To study whether selected TRIM family proteins mediate membrane repair in the heart and to understand the molecular mechanism of this process, we generated several versions of human MG53 and TRIM27 cDNAs, which were optimized for expression in different host organisms for protein production, including E. coli and CHO cells. To create MG53 and TRIM27 and their homo‐ and heterodimers, we performed structural analysis of all TRIM family proteins and their separate domains that are available in the RCSB Protein Data Bank (PDB). Our analysis showed that PRY‐SPRY domains of protein are within several angstroms spatially. This allowed us to propose that the distance between domains can be covered by a linker to generate proteins without losing their activity. Thus, oligomeric forms of TRIM family proteins were created by fusing their human monomeric variants in anti‐parallel orientation (tail‐to‐tail) . The therapeutic effects of TRIM proteins and their oligomeric forms on cardiac function and vulnerability to ischemia‐reperfusion injury will be further defined using in vitro and in vivo models. Support or Funding Information This work was supported by grant AR063084 from the National Institutes of Health and the Muscular Dystrophy Association (N.W.), Internal Muscle Health and Neuromuscular Disorders Program (L.G.) and the American Heart Association (AHA) program ( 14POST19990020 , L.G.).

Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin

Defective membrane repair in dysferlin-deficient muscular dystrophy

Dysferlin and the plasma membrane repair in muscular dystrophy

Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy

Dysferlin and muscle membrane repair

Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition

Annexins and Membrane Repair Dysfunctions in Muscular Dystrophies

Membrane repair of human skeletal muscle cells requires Annexin-A5

Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy

Deficient Sarcolemma Repair in ALS: A Novel Mechanism with Therapeutic Potential

Membrane Injury and Repair in the Muscular Dystrophies

Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion

Contribution of Oligomeric Forms of Tripartite Motif E3 Ubiquitin Ligase Proteins to Plasma Membrane Repair in Striated Muscle

Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5/TMEM16E-deficient patient muscle cells

Dysferlinopathy Fibroblasts Are Defective in Plasma Membrane Repair

Plasma Membrane Repair in Health and Disease

Dystrophy-associated caveolin-3 mutations reveal that caveolae couple IL6/STAT3 signaling with mechanosensing in human muscle cells

Non-Muscle Myosin Iia Facilitates Vesicle Trafficking for Mg53-Mediated Cell Membrane Repair

Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy

On the role of dysferlin in striated muscle: membrane repair, t‐tubules and Ca2+ handling